Skin test anergy among injection drug users recruited from community settings

Journal of Drug Issues

Volumn 28, Issue 4, 1998, Pages 891-904

  Lifson, Alan R ^b   Thompson, Suzanne ^a   Grant, Suzanne ^c   Hilk, Rose ^c   Lorvick, Jennifer ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CELLULAR IMMUNITY; CLONAL ANERGY; DELAYED HYPERSENSITIVITY; FEMALE; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIUM TUBERCULOSIS; SCREENING; SKIN TEST; TUBERCULIN TEST;

EID: 0032435866     PISSN: 00220426     EISSN: None     Source Type: Journal    
DOI: 10.1177/002204269802800404     Document Type: Article

References (29)

1. Bagasra, O. and L. Forman 1989 Functional analysis of lymphocytes subpopulations in experimental cocaine abuse. I. Dose-dependent activation of lymphocyte subsets. Clinical and Experimental Immunology 77 (2):289-293.
2. Birx, D.L., J. Brundage, K. Larson, R. Engler, L. Smith, E. Squire, G. Carpenter, M. Sullivan, J. Rhoads, C. Oster, W. James, G. Lupton, T. Wierzba, D. Burke, and R. Redfield 1993 The prognostic utility of delayed-type hypersensitivity skin testing in the evaluation of HIV-infected patients. Journal of the Acquired Immune Deficiency Syndromes 6 (11):1248-1257.
3. Blatt, S.P., C.W. Hendrix, C.A. Butzin, T.M. Freeman, W.W. Ward, R.E. Hensley, G.P. Melcher, D.J. Donovan, and R.N. Boswell 1993 Delayed-type hypersensitivity skin testing predicts progression to AIDS in HIV-infected patients. Annals of Internal Medicine 119 (3):177-184.
4. Brown, S.M., B. Stimmel, R.N. Taub, S. Kochwa, and R.E. Rosenfield 1974 Immunologic dysfunction in heroin addicts. Archives of Internal Medicine 134 (6):1001-1006.
5. Caiaffa, W.T., N.M.H. Graham, N. Galai, R.T. Rizzo, K.E. Nelson, and D. Vlahov 1995 Instability of delayed-type hypersensitivity skin test anergy in human immunodeficiency virus infection. Archives of Internal Medicine 155 (19):2111-2117.
6. Centers for Disease Control and Prevention 1997 Anergy skin testing and preventive therapy for HIV-infected persons: revised recommendations. Morbidity and Mortality Weekly Report 46 (No. RR-15):1-10. 1995 Essential components of a tuberculosis prevention and control program; and Screening for tuberculosis and tuberculosis infection in high-risk populations: recommendations of the Advisory Council for the Elimination of Tuberculosis. Morbidity and Mortality Weekly Report 44 (No. RR-11):1-34.
7. Centers for Disease Control and Prevention 1997 Anergy skin testing and preventive therapy for HIV-infected persons: revised recommendations. Morbidity and Mortality Weekly Report 46 (No. RR-15):1-10. 1995 Essential components of a tuberculosis prevention and control program; and Screening for tuberculosis and tuberculosis infection in high-risk populations: recommendations of the Advisory Council for the Elimination of Tuberculosis. Morbidity and Mortality Weekly Report 44 (No. RR-11):1-34.
8. Centers for Disease Control 1991 Purified protein derivative (PPD)-tuberculin anergy and HIV infection: guidelines for anergy testing and management of anergic persons at risk of tuberculosis. Morbidity and Mortality Weekly Report 40 (No. RR-5):27-33.
9. Chin, D.P., D. Osmond, K. Page-Shafer, J. Glassroth, M.J. Rosen, L.B. Reichman, P.A. Kvale, J.M. Wallace, W.K. Poole, and P.C. Hopewell 1996 Reliability of anergy skin testing in persons with HIV infection. American Journal of Respiratory and Critical Care Medicine 153 (6 Pt. 1):1982-1984.
10. Dolan, M.J., M. Clerici, S.P. Blatt, C.W. Hendrix, G.P. Melcher, R.N. Boswell, T.M. Freeman, W. Ward, R. Hensley, and G.M. Shearer. 1995 In vitro T cell function, delayed-type hypersensitivity skin testing, and CD4+ T cell subset phenotyping independently predict survival time in patients infected with human immonodeficiency virus. Journal of Infectious Diseases 172 (1):79-87.
11. Gordin, F.M., J.P. Matts, C. Miller, L.S. Brown, R. Hafner, S.L. John, M. Klein, A. Vaughn, C.L. Besch, G. Perez, S. Szabo, and W. El-Sadr 1997 A controlled trial of isoniazid in persons with anergy and human immunodeficiency virus infection who are at high risk for tuberculosis. New England Journal of Medicine 337 (5):315-320.
12. Gordin, F.M., P.M. Hartigan, N.G. Klimas, S.B. Zolla-Pazner, M.S. Simberkoff, and J.D. Hamilton 1994 Delayed-type hypersensitivity skin tests are an independent predictor of human immunodeficiency virus disease progression. Journal of Infectious Disease 169 (4):893-897.
13. Graham, N.M.H., K.E. Nelson, L. Solomon, M. Bonds, R.T. Rizzo, J. Scavotto, J. Astemborski, and D. Vlahov 1992 Prevalence of tuberculin positivity and skin test anergy in HIV-1 -seropositive and -seronegative intravenous drug users. Journal of the American Medical Association 267 (3):369-373.
14. Janis, E.M., D.W. Allen, M.J. Glesby, L.A. Carey, L.M. Mundy, R. Gopalan, and R.E. Chaisson 1996 Tuberculin skin test reactivity, anergy, and HIV infection in hospitalized patients. The American Journal of Medicine 100 (2):186-192.
15. Klein, T.W., C.A. Newton, and H. Friedman 1988 Suppression of human and mouse lymphocyte proliferation by cocaine. Advances in Biochemical Psychopharmacology 44:139-143.
16. Klimas, N.G., N.T. Blaney, R.O. Morgan, D. Chitwood, K. Milles, H. Lee, and M.A. Fletcher. 1991 Immune function and anti-HTLV-I/II status in anti-HIV-1-negative intravenous drug users receiving methadone. The American Journal of Medicine 90 (2):163-170.
17. Lifson, A.R., S.M. Grant, J. Lorvick, F.D. Pinto, H. He, S. Thompson, E.G. Keudell, M.J. Stark, R.E. Booth, and J.K. Watters 1997 Two-step tuberculin skin testing of injection drug users recruited from community-based settings. International Journal of Tuberculosis and Lung Disease 1(2):128-134.
18. Markowitz, N., N.I. Hansen, T.C. Wilcosky, P.C. Hopewell, J. Glassroth, P.A. Kvale, B.T. Mangura, D. Osmond, J.M. Wallace, M.J. Rosen, and L.B. Reichman 1993 Tuberculin and anergy testing in HIV-seropositive and HIV-seronegative persons. Annals of Internal Medicine 119 (3):185-193.
19. Mientjes, G.H., F. Miedema, E.J. van Ameijden, A.A. van den Hoek, P.T.A. Schellekens, M.T. Roos, and R.A. Coutinho 1991 Frequent injecting impairs lymphocyte reactivity in HIV-positive and HIV-negative drug users. AIDS 5(1):35-41.
20. Miller, W.C., N.M. Thielman, N. Swai, J.P. Cegielski, J. Shao, D. Ting, J. Mlalasi, D. Manyenga, and G.J. Lallinger 1996 Delayed-type hypersensitivity testing in Tanzanian adults with HIV infection. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 12(3):303-308.
21. Perlman, D.C., N. Salomon, M.P. Perkins, S. Yancovitz, D. Paone, and D.C. Des Jarlais 1995 Tuberculosis in drug users. Clinical Infectious Diseases 21(5):1253-1264.
22. Pesanti, E.L. 1994 The negative tuberculin test: tuberculin, HIV, and anergy panels. American Journal of Respiratory and Critical Care Medicine 149(6):1699-1709.
23. Reichman, L.B., C.P. Felton, and J.R. Edsall 1979 Drug dependence, a possible new risk factor for tuberculosis disease. Archives of Internal Medicine 139(3):337-339.
24. Selwyn, P.A., D. Hartel, V.A. Lewis, E.E. Schoenbaum, S.H. Vermund, R.S. Klein, A.T. Walker, and G.H. Friedland 1989 A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection. New England Journal of Medicine 320(9):545-550.
25. Sokal, J.E. 1975 Measurement of delayed skin-test responses. New England Journal of Medicine 293(10):501-502.
26. Watson, E.S., J.C. Murphy, H.N. ElSohly, M.A. ElSohly, and C.E. Turner 1983 Effects of the administration of coca alkaloids on the primary immune responses of mice: interaction with 9-tetrahydrocannabinol and ethanol. Toxicology and Applied Pharmacology 71(1):1-13.
27. Watters, J.K. and P. Biernacki 1989 Targeted sampling: options for the study of hidden populations. Social Problems 36(4):416-430.
28. Watters, J.K., M.J. Estilo, G.L. Clark, and J. Lorvick 1994 Syringe and needle exchange as HIV/AIDS prevention for injection drug users. Journal of the American Medical Association 271(2):115-120.
29. Wright, P.W., J.E. Crutcher, and D.B. Holiday 1995 Selection of skin test antigens to evaluate PPD anergy. Journal of Family Practice 41(1):59-64.